HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹206 Cr | ₹210 Cr | ₹277 Cr | ₹195 Cr | ₹222 Cr |
What is the latest Net Current Assets ratio of HIKAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹206 Cr |
| Mar2024 | ₹210 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹195 Cr |
| Mar2021 | ₹222 Cr |
How is Net Current Assets of HIKAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹206 Cr | -1.95 | |
| Mar2024 | ₹210 Cr | -24.32 | |
| Mar2023 | ₹277 Cr | 42.22 | |
| Mar2022 | ₹195 Cr | -12.05 | |
| Mar2021 | ₹222 Cr | - | |
Compare Net Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,888.3 Cr | -4.3% | 23.3% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.3% |
23.3% |
-29.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses